A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 507 participants.
Also called NCT01456169
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 507 participants
- Sponsor
- Registry
-
NCT01456169 -
2011-000220-16 -
U1111-1119-4743
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Bulgaria, Estonia, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, Serbia, Slovakia, Spain, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01456169. Randomized; quadruple masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2012-12 (actual). Results posted on 2014-04-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
- Condition
- Essential Hypertension
- Intervention (Drug)
- Azilsartan medoxomil/placebo
- Intervention (Drug)
- Azilsartan medoxomil - chlorthalidone
- Lead sponsor
- Takeda
Record details
- Record id
cardio:ct-nct01456169- Content hash
dcfd894e530ebeb9608c8f7cbb37d10954292f4ff71bdbbca3fc501490736ff1